Observe Medical receives significant order for medical consumables from a hospital region in the Nordic market

Report this content

Oslo 29 January 2021 – Observe Medical ASA (OSE: OBSERV), today announces that Observe Medical Group has received a significant order for medical consumables from a hospital region in the Nordic market.

Following the recent acquisition and integration of Sylak AB, Observe Medical has delivered strong sales performance and today announces a significant order for delivery of safety needles to a hospital region in the Nordic market. The current order represents a value of 5.8 mSEK, with delivery of the products during April and May 2021, with potential for further orders later in 2021.

“I am pleased to announce this significant order of safety needles, showcasing our sales performance and validating the strategically important synergies from the acquisition of Sylak. The professionalism of our sales team and their longstanding and trustful relations with our customers in the hospitals further enables the access to the target customers of Sippi®, currently launched in the Nordic market and selected European countries,” says Björn Larsson, CEO of Observe Medical.

The revenue from the order is expected to be included in the Q2 2021 financial reporting of Observe Medical.


For further information, please contact:

Björn Larsson, CEO, mobile: +46 76 620 17 25 E-mail: bjorn.larsson@observemedical.com


About Observe Medical

Observe Medical develops and markets and sells innovative hospital products that contribute to increased patient safety and a more efficient care system. The company’s ambition is to drive growth by leveraging its expertise in sales and commercialization of its broad portfolio of medical technology products, mainly in the areas of Urine measurement, Anesthesiology/ICUs and wound care, in combination with targeted M&A. The company’s headquarter is in Oslo, Norway and its operations is based out of Gothenburg, Sweden. Observe Medical has a direct sales organization in the Nordics and a distributor network internationally. Observe Medical's product Sippi® is the only automated digital urine meter with possibility for wireless data transfer to the hospital patient data management systems and hinders bacterial migration that can lead to urinary infections (Sippcoat®). Sippi® is CE marked and is currently being launched with focus on selected markets and hospitals in Nordics and in Europe.